About
Semler Scientific® is a healthcare technology company based in Santa Clara, California, founded in 2007. The company focuses on developing and marketing diagnostic products aimed at the early detection and treatment of chronic diseases, particularly vascular conditions. Its flagship product, QuantaFlo®, is an FDA-cleared point-of-care diagnostic system that measures arterial blood flow to detect peripheral arterial disease (PAD). This non-invasive test provides quick results, allowing healthcare providers to diagnose vascular diseases early, even in patients without symptoms. In addition to QuantaFlo, Semler Scientific offers a range of cloud-based solutions, including SemlerShield, SemlerVault, and SemlerAnalytics, which enhance diagnostic capabilities and data security. The company also launched SemlerHub in 2024, a platform for remote access and data integration related to QuantaFlo software. Semler Scientific emphasizes innovation, regulatory compliance, and customer support, with a strong focus on serving physicians and healthcare providers in cardiology, podiatry, and primary care. The company has also adopted a unique financial strategy by investing a portion of its treasury reserves in Bitcoin to protect shareholder value.
Technologies
Keywords
Company Information
-
Employees 79
-
Founded 2010
-
Annual Revenue $49225000
-
Total Funding $10010000
Location
2344 Walsh Ave, Santa Clara, California, United States, 95051-1301